Greenleaf Trust Has $15.41 Million Stake in The Procter & Gamble Company (NYSE:PG)

Greenleaf Trust raised its position in shares of The Procter & Gamble Company (NYSE:PG) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 105,174 shares of the company’s stock after buying an additional 9,111 shares during the period. Greenleaf Trust’s holdings in Procter & Gamble were worth $15,412,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of PG. Axiom Financial Strategies LLC increased its holdings in shares of Procter & Gamble by 7.0% during the first quarter. Axiom Financial Strategies LLC now owns 1,728 shares of the company’s stock worth $276,000 after buying an additional 113 shares in the last quarter. AMI Investment Management Inc. increased its holdings in shares of Procter & Gamble by 7.2% during the first quarter. AMI Investment Management Inc. now owns 3,461 shares of the company’s stock worth $529,000 after buying an additional 233 shares in the last quarter. LSV Asset Management increased its holdings in shares of Procter & Gamble by 5.7% during the first quarter. LSV Asset Management now owns 18,600 shares of the company’s stock worth $2,842,000 after buying an additional 1,000 shares in the last quarter. Ergoteles LLC bought a new stake in shares of Procter & Gamble during the first quarter valued at approximately $3,073,000. Finally, Wsfs Capital Management LLC grew its stake in shares of Procter & Gamble by 12.0% during the first quarter. Wsfs Capital Management LLC now owns 4,256 shares of the company’s stock valued at $650,000 after purchasing an additional 455 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.5 %

Shares of NYSE PG traded up $0.73 during midday trading on Friday, reaching $158.02. 12,028,669 shares of the stock were exchanged, compared to its average volume of 6,932,996. The business has a 50-day simple moving average of $159.13 and a two-hundred day simple moving average of $152.83. The company has a market capitalization of $371.82 billion, a price-to-earnings ratio of 26.31, a P/E/G ratio of 3.21 and a beta of 0.44. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $163.14. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The business’s quarterly revenue was up .6% compared to the same quarter last year. During the same period last year, the firm posted $1.37 earnings per share. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.45 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.55%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 67.34%.

Insider Buying and Selling

In related news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares in the company, valued at $768,256.49. The disclosure for this sale can be found here. Insiders have sold a total of 279,063 shares of company stock worth $43,187,745 over the last ninety days. Company insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on PG. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Royal Bank of Canada increased their price target on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Finally, The Goldman Sachs Group started coverage on shares of Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective on the stock. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $168.53.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.